Most importantly, Arora et al., 2018 report that decreased GJA1 expression leads to worse survival outcomes in patients, in several cancers including breast cancer [53], and another recent study reported Cx43 as an independent predictor of breast cancer patient prognosis and outcome [54]. Here, GJA1 is linked to breast cancer.